MML Investors Services’s iRadimed IRMD Stock Holding History

MML Investors Services’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+2,102	New	+$191K	﹤0.01%	3117

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MML Investors Services's IRMD Position: Q2 2026 in Review

MML Investors Services opened a new position in iRadimed (IRMD) in Q2 2026: 2,102 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #3117 among its holdings.

214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

MML Investors Services held 2,102 shares of iRadimed worth $201K as of Q2 2026.
iRadimed was a new MML Investors Services position in Q2 2026.
iRadimed made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #3117 holding.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.